Sealink Impex Pharma Private Limited

Sealink Impex Pharma Private Limited - chemicals and materials in Hyderabad, Telangana, India. FY 2026 financials and compliance.
CIN U24100TG2016PTC113769 Incorporated 29 December 2016 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company chemicals and materials
Data last updated
Revenue · FY 2023
-
Latest filing
EBITDA · FY 2023
*****
In full report
Net profit · FY 2023
*****
In full report
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
None
Secured borrowings
Company age
10 yrs
Est. 2016
Last financials
Mar 2024
Balance sheet date

About Sealink Impex Pharma Private Limited

Data last updated: 09 January 2026

Sealink Impex Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It specialises in industrial chemicals, a part of the broader chemicals and materials sector. Incorporated on 29 December 2016, the company has been in operation for over 10 years.

Registered with ROC Hyderabad under CIN U24100TG2016PTC113769.

Capital: an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. Formerly known as Esvee Technologies Private Limited. It is led by directors including Dinesh and Sigatapu Veeralakshmana Vardhan.

Last AGM: 30 September 2024. Financial statements filed for year ended 31 March 2024. Office: 1St Floor Trendz Avenue Plot No. 12 Sy No.31 – 36 Gafoor Nagar Madhapur, Hyderabad, Telangana, India – 500081.

The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of Sealink Impex Pharma Private Limited
CIN U24100TG2016PTC113769
Registration Number 113769
Incorporation Date 29 December 2016
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
Key People
Dinesh Additional Director Sigatapu Veeralakshmana Vardhan Director Ganesh Harry Additional Director
Contact Details
  • Email
    *****@*****.com
  • Telephone
    +91-****-******
  • Website
    **************
  • Social Media
    **************
  • Registered Address
    1St Floor Trendz Avenue Plot No. 12 Sy No.31 – 36 Gafoor Nagar Madhapur, Hyderabad, Telangana, India – 500081
  • Industry
    Chemicals and Materials, Industrial Chemicals
Company report
Sealink Impex Pharma Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Sealink Impex Pharma Private Limited report

Financials, compliance, directors, charges, ownership and filings for Sealink Impex Pharma Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Sealink Impex Pharma Private Limited

Sealink Impex Pharma Private Limited has one previous CIN (Corporate Identification Number): U72900TG2016PTC113769. The current CIN is U24100TG2016PTC113769, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
U24100TG2016PTC113769 Current
U72900TG2016PTC113769 Previous

Auditor Details of Sealink Impex Pharma Private Limited

Sealink Impex Pharma Private Limited is audited by Y S REDDY & CO for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
Y S REDDY & CO blur-value blur-value blur-value

Board of Directors of Sealink Impex Pharma Private Limited

Sealink Impex Pharma Private Limited is currently managed by 4 directors, with 1 former director having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Dinesh
Also directs: Rapidus Consumer Healthcare Llp, Mikaku Health Llp, Aavishkar Oral Strips Private Limited and 2 more
Additional Director 22 Feb 2019 7 Years 4 Months Current
Sigatapu Veeralakshmana Vardhan
Also directs: Sways Software Consulting Llp, Gincom Ventures Llp, Calyxan Labs Private Limited and 5 more
Director 29 Dec 2016 9 Years 6 Months Current
Ganesh Harry
Also directs: Calyxan Labs Private Limited, Sealink Impex Private Limited
Additional Director 22 Feb 2019 7 Years 4 Months Current
Trinath Tummepalli
Also directs: Mahakram Health Llp, Inline Pharmaceuticals Private Limited, Oak Vance Life Sciences Private Limited and 2 more
Additional Director 22 Feb 2019 7 Years 4 Months Current
View all directors

Financials of Sealink Impex Pharma Private Limited FY 2024 filings available

Sealink Impex Pharma Private Limited reported revenue of ₹- (up ) for FY 2023. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue
-
Metrics
*****
*****
*****
*****
*****
Revenue
Revenue from Operations
*****
*****
*****
*****
*****
Revenue Growth %
*****
*****
*****
*****
*****
Other Income
*****
*****
*****
*****
*****
Total Revenue
*****
*****
*****
*****
*****
Expenses
Total Expenses
*****
*****
*****
*****
*****
Raw Material Cost
*****
*****
*****
*****
*****
Change in Inventory FG
*****
*****
*****
*****
*****
Change in Inventory WIP
*****
*****
*****
*****
*****
Purchase of Traded Goods
*****
*****
*****
*****
*****
Employee Cost
*****
*****
*****
*****
*****
Managerial Remuneration
*****
*****
*****
*****
*****
Audit Fees
*****
*****
*****
*****
*****
Insurance
*****
*****
*****
*****
*****
Power & Fuel
*****
*****
*****
*****
*****
Interest
*****
*****
*****
*****
*****
Depreciation
*****
*****
*****
*****
*****
Other Expenses
*****
*****
*****
*****
*****
Profitability
EBITDA (Operating Profit)
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
Exceptional Items
*****
*****
*****
*****
*****
Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Exceptional & Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Tax
*****
*****
*****
*****
*****
Tax & Net Profit
Tax Expense
*****
*****
*****
*****
*****
Current Tax
*****
*****
*****
*****
*****
Deferred Tax
*****
*****
*****
*****
*****
Profit from Discontinued Operations
*****
*****
*****
*****
*****
Tax on Discontinued Operations
*****
*****
*****
*****
*****
Profit
*****
*****
*****
*****
*****
Net Margin %
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Shareholders' Funds
Total Shareholders' Funds
*****
*****
*****
*****
*****
Equity Capital
*****
*****
*****
*****
*****
Reserves & Surplus
*****
*****
*****
*****
*****
Money Against Warrants
*****
*****
*****
*****
*****
Other Equity
*****
*****
*****
*****
*****
Non-Current Liabilities
Total Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Borrowings
*****
*****
*****
*****
*****
Deferred Tax Liabilities
*****
*****
*****
*****
*****
Other Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Provisions
*****
*****
*****
*****
*****
Current Liabilities
Total Current Liabilities
*****
*****
*****
*****
*****
Short-Term Borrowings
*****
*****
*****
*****
*****
Trade Payables
*****
*****
*****
*****
*****
Other Current Liabilities
*****
*****
*****
*****
*****
Short-Term Provisions
*****
*****
*****
*****
*****
Total Equity & Liabilities
*****
*****
*****
*****
*****
Non-Current Assets
Non-Current Assets
*****
*****
*****
*****
*****
Tangible Assets
*****
*****
*****
*****
*****
Intangible Assets
*****
*****
*****
*****
*****
Capital WIP
*****
*****
*****
*****
*****
Intangibles Under Dev
*****
*****
*****
*****
*****
Investments
*****
*****
*****
*****
*****
Deferred Tax Assets
*****
*****
*****
*****
*****
LT Loans & Advances
*****
*****
*****
*****
*****
Other Non-Current Assets
*****
*****
*****
*****
*****
Current Assets
Current Assets
*****
*****
*****
*****
*****
Current Investments
*****
*****
*****
*****
*****
Inventories
*****
*****
*****
*****
*****
Trade Receivables
*****
*****
*****
*****
*****
Cash & Bank Balance
*****
*****
*****
*****
*****
ST Loans & Advances
*****
*****
*****
*****
*****
Other Current Assets
*****
*****
*****
*****
*****
Total Assets
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Cash from Operating Activities (CFO)
Profit Before Tax
*****
*****
*****
*****
*****
Non-Cash Adjustments
*****
*****
*****
*****
*****
+ Interest Expense
*****
*****
*****
*****
*****
+ Depreciation
*****
*****
*****
*****
*****
+/- Unrealized Forex
*****
*****
*****
*****
*****
- Dividend Income
*****
*****
*****
*****
*****
- Interest Income
*****
*****
*****
*****
*****
+/- Other Non-Cash Items
*****
*****
*****
*****
*****
Changes in Working Capital
*****
*****
*****
*****
*****
+/- Inventory
*****
*****
*****
*****
*****
+/- Debtors
*****
*****
*****
*****
*****
+/- Creditors
*****
*****
*****
*****
*****
Reconciliation Adjustments
*****
*****
*****
*****
*****
Cash Generated from Operations
*****
*****
*****
*****
*****
Income Taxes Paid
*****
*****
*****
*****
*****
Net CFO (Cash from Operations)
*****
*****
*****
*****
*****
Cash from Investing Activities (CFI)
Acquisitions & Disposals
*****
*****
*****
*****
*****
Disposal of Subsidiaries
*****
*****
*****
*****
*****
Acquisition of Subsidiaries
*****
*****
*****
*****
*****
Capex
*****
*****
*****
*****
*****
Purchase of Fixed Assets
*****
*****
*****
*****
*****
Sale of Fixed Assets
*****
*****
*****
*****
*****
Other Investing Cash Flows
*****
*****
*****
*****
*****
Net CFI (Cash from Investing)
*****
*****
*****
*****
*****
Cash from Financing Activities (CFF)
Equity Issuance
*****
*****
*****
*****
*****
Debt Raised
*****
*****
*****
*****
*****
Debt Repaid
*****
*****
*****
*****
*****
Dividends Paid
*****
*****
*****
*****
*****
Interest Paid
*****
*****
*****
*****
*****
Net CFF (Cash from Financing)
*****
*****
*****
*****
*****
Net Cash Position
Net Change in Cash (Pre-Forex)
*****
*****
*****
*****
*****
Closing Cash & Equivalents
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Liquidity
Current Ratio
*****
*****
*****
*****
*****
Quick Ratio
*****
*****
*****
*****
*****
Cash Ratio
*****
*****
*****
*****
*****
Efficiency
Inventory Days
*****
*****
*****
*****
*****
Debtor Days
*****
*****
*****
*****
*****
Creditor Days
*****
*****
*****
*****
*****
Cash Conversion Cycle
*****
*****
*****
*****
*****
Asset Turnover
*****
*****
*****
*****
*****
Profitability
Net Profit Margin %
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
ROE %
*****
*****
*****
*****
*****
ROCE %
*****
*****
*****
*****
*****
Net Worth Margin %
*****
*****
*****
*****
*****
Growth
Revenue Growth %
*****
*****
*****
*****
*****
Leverage
Equity Multiplier
*****
*****
*****
*****
*****
Debt / EBITDA
*****
*****
*****
*****
*****
Solvency
D/E Ratio
*****
*****
*****
*****
*****
ICR
*****
*****
*****
*****
*****

Consolidated Statements

Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.

Unlock Complete Financial History (FY 2015 – Latest)
Standalone & Consolidated - Income Statement, Balance Sheet, Cash Flow, Financial Ratios and Growth Trends with 10+ years of line-item data.
10+ years of data Line-item breakdown Balance Sheet detail Cash Flow analysis 20+ ratios & metrics Downloadable PDF

Shareholding Pattern of Sealink Impex Pharma Private Limited

As of FY 2023, Sealink Impex Pharma Private Limited's shareholding pattern shows 100.00% by promoters. The promoters hold a majority stake, indicating strong promoter control.

2025
YEAR
38.19% Promoters
25.22% DII (Domestic Institutional)
10.28% FII (Foreign Institutional)
25.89% Public
2.42% Others
Shareholding Trend
Year 2025
Promoters 33.19%
DII 23.22%
FII 18.28%
Public 22.89%
Others 2.42%

Charges & Borrowings Sealink Impex Pharma Private Limited

Sealink Impex Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Sealink Impex Pharma Private Limited

View historical data on people associated with Sealink Impex Pharma Private Limited, including employment history and EPFO contributions.

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Sealink Impex Pharma Private Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Sealink Impex Pharma Private Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Sealink Impex Pharma Private Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Sealink Impex Pharma Private Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Sealink Impex Pharma Private Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Sealink Impex Pharma Private Limited

MSME Payment Delays by Sealink Impex Pharma Private Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Sealink Impex Pharma Private Limited

Subsidiaries & Group Companies of Sealink Impex Pharma Private Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Sealink Impex Pharma Private Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Sealink Impex Pharma Private Limited

MCA Filings & Documents of Sealink Impex Pharma Private Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Sealink Impex Pharma Private Limited

Activity
30 Sep 2024
Sealink Impex Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Activity
31 Mar 2024
Sealink Impex Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Directors
22 Feb 2019
Dinesh was appointed as a Additional Director on 22 Feb 2019 & has been associated with this company since 7 years 4 months.
Directors
22 Feb 2019
Ganesh Harry was appointed as a Additional Director on 22 Feb 2019 & has been associated with this company since 7 years 4 months.
Directors
22 Feb 2019
Trinath Tummepalli was appointed as a Additional Director on 22 Feb 2019 & has been associated with this company since 7 years 4 months.
Directors
29 Dec 2016
Sigatapu Veeralakshmana Vardhan was appointed as a Director on 29 Dec 2016 & has been associated with this company since 9 years 6 months.

Frequently Asked Questions about Sealink Impex Pharma Private Limited

Sealink Impex Pharma Private Limited is an active private limited company in the chemicals and materials sector based in Hyderabad, Telangana, India. It was incorporated on 29 December 2016 (10+ years old) and is registered under CIN U24100TG2016PTC113769.

The current directors of Sealink Impex Pharma Private Limited are:

The primary industry of Sealink Impex Pharma Private Limited is chemicals and materials. The company specifically operates in industrial chemicals. The company is currently active in this sector.

Sealink Impex Pharma Private Limited can be reached at the registered office: 1St Floor Trendz Avenue Plot No. 12 Sy No.31 – 36 Gafoor Nagar Madhapur, Hyderabad, Telangana, India – 500081.

The authorised capital is ₹1 Lakh, and the paid-up capital is ₹1 Lakh.

The company has its registered office at 1St Floor Trendz Avenue Plot No. 12 Sy No.31 – 36 Gafoor Nagar Madhapur, Hyderabad, Telangana, India – 500081.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available